Disclosed herein are small molecule compounds capable of disrupting Kv2.1-syntaxin binding. The compounds are useful for treating a variety of neurological disorders, diseases, and injuries.

A process for the preparation of a compound of formula (II) where Et=ethyl; Bn=benzyl and Ph=phenyl; comprises the step of reacting a cyclic amine with an alkylating agent to form a compound of formula II, wherein the process is solvent-free. The chloroalkyl N-substituted cyclic amines of formula II may be used in the preparation of active pharmaceutical ingredients or intermediates therefor comprising these moieties in their molecular structure.

A process for the preparation of a compound of formula (II) where Et=ethyl; Bn=benzyl and Ph=phenyl; comprises the step of reacting a cyclic amine with an alkylating agent to form a compound of formula II, wherein the process is solvent-free. The chloroalkyl N-substituted cyclic amines of formula II may be used in the preparation of active pharmaceutical ingredients or intermediates therefor comprising these moieties in their molecular structure.

Disclosed herein are small molecule compounds capable of disrupting Kv2.1-syntaxin binding. The compounds are useful for treating a variety of neurological disorders, diseases, and injuries.

The present invention relates to a copolymer having several azide functionalities that can be prepared by cationic ring opening polymerisation. The copolymer comprises a first monomer unit and a second monomer unit which are different from each other.